Clinical Trial Update: Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC [NA]

View source ↗

Summary

A clinical trial update indicates that a study comparing neoadjuvant immunochemotherapy to chemoradiotherapy in esophageal squamous cell carcinoma has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Yongtao Han | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | NA | Status: COMPLETED